联影医疗（688271）披露2025年度业绩快报公告，2月25日股价上涨0.29%

Core Viewpoint - Shanghai United Imaging Healthcare Co., Ltd. reported significant growth in its 2025 annual performance, driven by innovative product launches and market expansion [1] Financial Performance - Total revenue for 2025 reached 1,382,064.02 million yuan, representing a year-on-year increase of 34.18% [1] - Net profit attributable to shareholders was 188,779.84 million yuan, showing a year-on-year growth of 49.60% [1] - Net profit excluding non-recurring gains and losses increased by 77.01% year-on-year [1] - Total assets amounted to 3,280,039.60 million yuan, reflecting a 17.00% year-on-year growth [1] - Shareholders' equity attributable to the parent company was 2,159,024.54 million yuan, up by 8.48% year-on-year [1] Market Factors - The growth in performance is attributed to the launch of innovative products, increased recognition of high-end products, expansion in domestic and international markets, and the implementation of domestic medical equipment renewal policies [1]